Gerard Caelles

Gerard Caelles

Company: Splice Bio

Job title: Chief Business Officer


Gerard joined SpliceBio in 2016 as the responsible for Business Development operations. Prior to joining SpliceBio, Gerard served as the Business Development Manager at Bionure, where he was focused on business development and partnering around the company’s novel candidate in the orphan neuro-ophthalmology space, as well as on fundraising efforts. Gerard holds a BSc in Biotechnology from Universitat Autònoma de Barcelona.


Panel Discussion: Defining the Future of Large Gene Delivery to the Eye 3:40 pm

Discussing innovative approaches being developed to overcome the limited cargo capacity of AAV vectors What key challenges remain in bringing these methods to the mainstream and how are industry working to overcome them? Predicting the future direction for large gene delivery to the eyeRead more

day: Conference Day One

Overcoming the AAV Capacity Challenge 9:00 am

An overview of the gene-carrying capacities of commonly used vectors in ocular gene therapy delivery Acknowledging the limited packaging size of AAV vectors, what are the benefits and drawbacks of dual AAV approaches? Exploring protein splicing AAV gene therapy for large gene delivery, and their potential benefits Understanding novel, non-viral, large-gene delivery approaches, their potential…Read more

day: Delivery Stream 1

Delivering Beyond 4.7 kb: Protein Splicing AAV Gene Therapy in Stargardt Disease 2:20 pm

A true platform: an engineered split intein to rule them all Protein Splicing 3.0: cassette design technology Building a pipeline in ophthalmology and beyondRead more

day: Preclinical 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.